Tetrahydrofuran
Medchemexpress LLC Ceftaroline 10mg | 189345-04-8 | 10MG
T-91825 (PPI-0903M) an N-phosphono-type cephalosporin is the active form of TAK-599 T-91825 is active against both gram-positive and gram-negative bacteria[1 [2
Medchemexpress LLC Sar-Arg-Val-Tyr-Val-His-NH2 | 2410957-04-7 | 96.6% | 742.87 | 5 MG
Sar-Arg-Val-Tyr-Val-His-NH2 is a Gq-biased agonist. It exhibits 10-fold larger molecular efficacies at the AT1R-Gq fusion protein compared with the AT1R-βarr2 fusion protein.
- Gq-biased agonist
- High purity of 96.6%
- Molecular weight of 742.87
- Stable under recommended storage conditions
- Useful for research on Angiotensin Receptors and GPCR/G Protein pathways
Medchemexpress LLC Linzagolix | 935283-04-8 | 99.7% | 508.42 | 100 MG
Linzagolix is a potent, non-peptide, and orally active GnRH antagonist. It can be used for uterine fibroids, endometriosis, and adenomyosis research. For research use only, not for sale to patients.
- Potent GnRH antagonist
- Non-peptide compound
- Orally active
- Used for uterine fibroids research
- Used for endometriosis research
- Used for adenomyosis research
Medchemexpress LLC (R)-Tetrahydrofuran-2-yl-methylamine | 7202-43-9 | ≥97.0% | 101.15 | 500 MG
(R)-Tetrahydrofuran-2-yl-methylamine is a synthetic intermediate useful for pharmaceutical synthesis.
- Useful for pharmaceutical synthesis.
Supply Solutions Burdick & Jackson - Filter Column 8ml (50/PK)
Burdick & Jackson - Filter Column 8ml (50/PK)
Medchemexpress LLC 1-(1-ethylpiperidin-4-yl)sulfonyl-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea | 2260969-36-4 | MFCD34579587 | 99.5% | C20H29N3O3S | 10MG
Selnoflast is an orally active, potent, selective, and reversible small-molecule inhibitor of the NLRP3 inflammasome for research use. It is supplied as a white to off-white solid with high reported purity, and the manufacturer provides solubility and storage guidance for preparation and stability in in vitro and preclinical workflows.
- Potent and selective NLRP3 inflammasome inhibition.
- Reversible small-molecule mechanism enabling temporal studies.
- High reported purity for consistent experimental results.
- Solid form suitable for standard laboratory storage and handling.
- Documented solubility in DMSO and alkaline media with preparation notes.
- Specified storage recommendations for powder and solution stability.
- Multiple pack sizes available to support different study scales.
Medchemexpress LLC Csf1r-in-1 | 2095849-04-8 | 98.0% | 479.45 g/mol | C25H20F3N5O2 | 10 MG
CSF1R-IN-1 is a potent small-molecule inhibitor of colony stimulating factor 1 receptor (CSF1R) with sub-nanomolar cellular potency. It is supplied for research use to probe CSF1R signaling, macrophage biology, and related disease models.
- Potent CSF1R inhibition with reported IC50 of 0.5 nM.
- High purity: 98.04%.
- Molecular formula C25H20F3N5O2 and molecular weight 479.45 g/mol.
- Available in powder and ready-to-use DMSO solutions; common pack sizes include 10 mg.
- Storage: powder at -20 °C; in solvent at -80 °C (up to 6 months) or -20 °C (up to 1 month).
- For research use only, not intended for human or veterinary use.
eMolecules 96-47-9 | 2-Methyltetrahydrofuran | Oakwood Chemicals | MFCD00005367 | 86.134 | C5H10O | 99.000 | CC1CCCO1 | 2kg | 480143995
2-Methyltetrahydrofuran | Oakwood Chemicals | 96-47-9 | MFCD00005367 | 86.134 | C5H10O | 99.000 | CC1CCCO1 | 2kg | 480143995
Medchemexpress LLC 4-Hydroxyantipyrine | 1672-63-5 | 99.9% | 100 MG
4-Hydroxyantipyrine (4-Hydroxyphenazone; NSC 174055) is the major metabolite of Antipyrine and can function as a biodistribution promoter. It can increase the distribution of the concentration ratio of Citicoline and Antipyrine in the brain.
- Major metabolite of Antipyrine
- Can act as a biodistribution promoter
- Increases distribution of concentration ratio of Citicoline and Antipyrine in the brain
- Increases the tissue-to-plasma concentration ratio of Citicoline in the brain and liver
- Increases the tissue-to-plasma concentration ratio of thiopental sodium in the brain, liver, and heart
- Enhances the blood-brain barrier (BBB) permeability of Antipyrine
Medchemexpress LLC Isoformononetin | 486-63-5 | 10 MG
Isoformononetin is an analog of Daidzein with immunoprotective effects, inhibiting the differentiation of Th17 and B-cells lymphopoiesis to promote osteogenesis in estrogen-deficient bone loss conditions.
- Molecular formula: C₁₆H₁₂O₄
- Molecular weight: 268.26
- Storage: 4°C, protected from light; in solvent: -80°C for 6 months, -20°C for 1 month (protected from light)
- Solubility (in vitro): DMSO at 250 mg/mL (931.93 mM), requires ultrasonic
- Usage caution: Product has not been fully validated for medical applications; for research use only
Medchemexpress LLC Isoformononetin | 486-63-5 | 5 MG
Isoformononetin is an analog of Daidzein with immunoprotective effects.
- Inhibits the differentiation of Th17 cells
- Inhibits B-cell lymphopoiesis
- Promotes osteogenesis in estrogen-deficient bone loss conditions
eMolecules 121138-01-0 | 3-Iodotetrahydrofuran | Ambeed | MFCD09878873 | 198.003 | C4H7IO | 98.000 | IC1CCOC1 | 1g | 600842500
3-Iodotetrahydrofuran | Ambeed | 121138-01-0 | MFCD09878873 | 198.003 | C4H7IO | 98.000 | IC1CCOC1 | 1g | 600842500
Medchemexpress LLC 1,1'-biphenyl-bis(methylene) bis(4-(4-chlorophenyl)methylamino-quinolinium) dibromide | 850807-63-5 | 98.4% | 877.53 g/mol | C46H38Br2Cl2N4 | 100 MG
RSM-932A is a research small-molecule inhibitor of choline kinase alpha (ChoKα) developed for preclinical oncology studies. It exhibits selective enzymatic inhibition, antiproliferative activity across multiple tumor-derived cell lines, and antitumor efficacy in xenograft models. Supplied as a solid for laboratory research.
- Specific inhibitor of choline kinase alpha.
- Enzyme IC50: ~1 μM for ChoKα and ~33 μM for ChoKβ.
- In vitro antiproliferative activity with IC50s ≈1.3-7.1 μM across cell lines.
- Demonstrated antitumor efficacy in xenograft models.
- High supplied purity (~98.4%) and storage stability when sealed and protected from moisture and light.
Medchemexpress LLC Vebicorvir (ABI-H0731) | 2090064-66-5 | 99.7% | 467.44 | 100 MG
Vebicorvir (ABI-H0731) is a first-generation hepatitis B virus (HBV) core protein inhibitor. It suppresses covalently closed circular DNA (cccDNA) formation in two de novo infection models with EC50s from 1.84 μM to 7.3 μM.
- Inhibits pgRNA, HBeAg, and HBsAg production, with EC50s of 2.68 μM, 4.95 μM, and 7.30 μM, respectively.
- Acts as an inhibitor of pgRNA encapsidation and rcDNA synthesis.